首页 > 市场调查报告书 > 食物/饮料

机能性食品

市场调查报告书

商品编码

1459644

全球癌症照护临床营养市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测

Global Clinical Nutrition For Cancer Care Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年03月01日 | 出版商:

Value Market Research | 英文 229 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

预计到 2032 年，全球癌症护理临床营养市场的市场规模将从 2023 年的 58.4 亿美元达到近 99.5 亿美元，2024-2032 年研究期间CAGR为 6.1%。

癌症护理的临床营养涉及专门的营养干预措施，以在整个治疗过程中为癌症患者提供支持。根据个人需求，临床营养策略可解决与癌症相关的营养挑战，例如体重减轻、营养不良和治疗相关的副作用。这些干预措施旨在提高癌症患者的整体健康状况，优化治疗结果，并提高癌症治疗期间和治疗后的生活品质。

市场动态

在多种因素的推动下，癌症护理市场的临床营养正在显着增长，这凸显了营养在支持癌症患者整个治疗过程中的关键作用。一个主要驱动因素是全球癌症盛行率不断上升，导致接受癌症治疗的人数不断增加，而癌症治疗往往会影响营养状况。临床营养在管理与癌症治疗相关的营养挑战方面发挥关键作用，包括化疗和放疗引起的副作用、营养不良和体重减轻。医疗保健提供者认识到量身定制的营养干预措施对于改善患者的治疗结果、提高他们的生活品质并支持身体耐受癌症治疗的能力的重要性。此外，对营养、免疫功能和癌症结果之间联繫的不断了解有助于越来越多地采用专门的临床营养方案。将基于证据的营养策略整合到癌症护理方案中，例如肠内和肠外营养，进一步推动市场的成长。随着癌症照护变得越来越个人化，注重患者的整体健康，癌症照护市场的临床营养不断创新，为医疗保健专业人员提供了必要的工具，以满足接受癌症治疗的个人的复杂营养需求。然而，某些因素，例如有限的认识、复杂的治疗方案和经济考虑，可能会限制癌症护理市场中临床营养的成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球癌症护理临床营养市场的各个细分市场进行了包容性评估。癌症护理行业临床营养的增长和趋势为本研究提供了整体方法。

市场区隔

癌症护理临床营养市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按产品分类

口服营养
肠外营养
肠内餵食配方

按阶段

成人
儿科

按销售管道

在线的
零售
机构销售

区域分析

本节涵盖区域展望，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲癌症护理临床营养市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。癌症护理临床营养市场的主要参与者包括雅培营养公司、辉瑞公司、拜耳公司、雀巢健康科学公司、葛兰素史克公司、百特国际公司、大冢控股有限公司、美赞臣公司、有限责任公司、 Danone Nutricia, Victus, Inc. 本部分包含竞争格局的整体视图，其中包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概览、合作、新产品开发、新产品发布以及其他事态发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区国家/地区销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 9 章：癌症护理公司临床营养的竞争格局

癌症护理临床营养市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 10 章：公司简介

公司股份分析
市场集中度
Abbott Nutrition

公司简介
公司收入
产品
最近的发展

Pfizer Inc.

公司简介
公司收入
产品
最近的发展

Bayer AG

公司简介
公司收入
产品
最近的发展

Nestle Health Science SA

公司简介
公司收入
产品
最近的发展

GlaxoSmithKline plc

公司简介
公司收入
产品
最近的发展

Baxter International Inc.

公司简介
公司收入
产品
最近的发展

Otsuka Holdings Co. Ltd.

公司简介
公司收入
产品
最近的发展

Mead Johnson & Company LLC

公司简介
公司收入
产品
最近的发展

Danone Nutricia

公司简介
公司收入
产品
最近的发展

Victus Inc.

公司简介
公司收入
产品
最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

简介目录图表

Product Code: VMR112114002

The global demand for Clinical Nutrition For Cancer Care Market is presumed to reach the market size of nearly USD 9.95 Billion by 2032 from USD 5.84 Billion in 2023 with a CAGR of 6.1% under the study period 2024 - 2032.

Clinical nutrition for cancer care involves specialized nutritional interventions to support cancer patients throughout their treatment journey. Tailored to individual needs, clinical nutrition strategies address the nutritional challenges associated with cancer, such as weight loss, malnutrition, and treatment-related side effects. These interventions aim to enhance the overall well-being of cancer patients, optimize treatment outcomes, and improve their quality of life during and after cancer therapy.

MARKET DYNAMICS

The clinical nutrition for cancer care market is witnessing significant growth driven by multiple factors that highlight the pivotal role of nutrition in supporting cancer patients throughout their treatment journey. A primary driver is the increasing prevalence of cancer globally, leading to a growing population of individuals undergoing cancer therapies that often impact nutritional status. Clinical nutrition plays a critical role in managing the nutritional challenges associated with cancer treatment, including chemotherapy and radiation therapy-induced side effects, malnutrition, and weight loss. Healthcare providers recognize the importance of tailored nutrition interventions to improve patients' outcomes, enhance their quality of life, and support the body's ability to tolerate cancer therapies. Additionally, the evolving understanding of the link between nutrition, immune function, and cancer outcomes contributes to the rising adoption of specialized clinical nutrition protocols. Integrating evidence-based nutritional strategies in cancer care protocols, such as enteral and parenteral nutrition, further propels the market's growth. As cancer care becomes increasingly personalized, focusing on holistic patient well-being, the clinical nutrition for cancer care market continues to innovate, providing healthcare professionals with essential tools to address the complex nutritional needs of individuals undergoing cancer treatment. However, certain factors, such as limited awareness, complex treatment protocols, and economic considerations, may restrict the growth of clinical nutrition in the cancer care market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of clinical nutrition for cancer care. The growth and trends of clinical nutrition for cancer care industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the clinical nutrition for cancer care market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Oral Nutrition
Parenteral Nutrition
Enteral Feeding Formulas

By Stage

Adult
Pediatric

By Sales Channel

Online
Retail
Institutional Sales

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Clinical Nutrition For Cancer Care market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Clinical Nutrition For Cancer Care market include Abbott Nutrition, Pfizer Inc., Bayer AG, Nestle Health Science S.A., GlaxoSmithKline plc, Baxter International Inc., Otsuka Holdings Co., Ltd., Mead Johnson & Company, LLC, Danone Nutricia, Victus, Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . CLINICAL NUTRITION FOR CANCER CARE - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Stage
- 3.7.3 Market Attractiveness Analysis By Sales Channel
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CLINICAL NUTRITION FOR CANCER CARE MARKET ANALYSIS BY PRODUCT

5.1 Overview by Product
5.2 Historical and Forecast Data
5.3 Analysis by Product
5.4 Oral Nutrition Historic and Forecast Sales by Regions
5.5 Parenteral Nutrition Historic and Forecast Sales by Regions
5.6 Enteral Feeding Formulas Historic and Forecast Sales by Regions

6 . GLOBAL CLINICAL NUTRITION FOR CANCER CARE MARKET ANALYSIS BY STAGE

6.1 Overview by Stage
6.2 Historical and Forecast Data
6.3 Analysis by Stage
6.4 Adult Historic and Forecast Sales by Regions
6.5 Pediatric Historic and Forecast Sales by Regions

7 . GLOBAL CLINICAL NUTRITION FOR CANCER CARE MARKET ANALYSIS BY SALES CHANNEL

7.1 Overview by Sales Channel
7.2 Historical and Forecast Data
7.3 Analysis by Sales Channel
7.4 Online Historic and Forecast Sales by Regions
7.5 Retail Historic and Forecast Sales by Regions
7.6 Institutional Sales Historic and Forecast Sales by Regions

8 . GLOBAL CLINICAL NUTRITION FOR CANCER CARE MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE CLINICAL NUTRITION FOR CANCER CARE COMPANIES

9.1. Clinical Nutrition For Cancer Care Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF CLINICAL NUTRITION FOR CANCER CARE INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Abbott Nutrition
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Pfizer Inc.
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Bayer AG
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Nestle Health Science S.A.
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. GlaxoSmithKline plc
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Baxter International Inc.
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Otsuka Holdings Co. Ltd.
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Mead Johnson & Company LLC
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. Danone Nutricia
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. Victus Inc.
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments